Latest news for SOHM (OTC:SHMN) Stock

SOHM Inc is a pharmaceutical manufacturer that produces and markets generic drugs for all treatment categories. Its services include OTC - Page Under Construction, RX: Generic CDMO Services, and ABBIE Systems. The organization markets and sells its generic drugs globally but focuses on emerging markets in Africa, Latin America, Southeast Asia, and the European Union. It recognizes revenue upon the accrual of interest earned on the tax lien certificates owned, as well as liquidating revenue from properties sold that the Company received through the settlement of unredeemed tax lien certificates.

SOHM Inc

SOHM files provisional patent on its ABBIE 'smart gene-editing' platform

SHMN

Biotech

Press Releases

General

SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024

News

SOHM, Inc. Announces its ABBIE Genome Editing Technology Successfully Engineered a T-cell immunotherapy from a Healthy Human Donor

Shares of this BioPharma on a Tear as it Successfully Engineered a T-Cell From a Healthy Human Donor

SOHM, Inc., Announce a New Collaboration and Joins Forces with Stanford University

Contracts

SOHM, Inc. has signed the Manufacturing and Supply of Skincare Topical Products with New Export Customers

SOHM, Inc. has Received ABBIE Technology Kits' Pre-Launch Pre-Orders

SOHM, Inc. Continues to Build its IP Portfolio in the Gene Editing and Cell Engineering Space

Management

SOHM, Inc. Announce Dr. David Zarling Onboard as Senior Product Development Advisor

SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan's Patent Office (特許庁, Tokkyochō, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes

SOHM, Inc. Announce Dr. Wei Zhu Onboard as Senior Marketing and Sales Consultant

SOHM

Comments

SOHM

News

Latest news for SOHM (OTC:SHMN) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga